amycretin vs retatrutide Cagrilintide retatrutide: amylin analogue vs triple agonist compared Amycretin Trial Shows Promising Weight
Description
Weight loss is correlated with BP reduction in middle-aged and older T2DM patients [135]
These findings may explain the mechanism behind this rare clinical entity
Monitor: Weekly glucose, energy logs
It is formulated to support immunity, energy production, and bone strength
These events are often dose-dependent, with higher doses of retatrutide generally resulting in a higher incidence of gastrointestinal adverse events
